Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
1 CALL ON FILE
ADXN
— Addex Therapeutics Ltd
NASDAQ
FULL STOCK PAGE →
Q3 2025 Earnings Call Summary
DEC 4, 2025
REVENUE
$29724
-18.3%
NET MARGIN
-5306.3%
-244.6 PTS
EPS
-$1.67
+34.8%
FREE CASH FLOW
-$533203
-27.0%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 1
OLDER CALL →